Reed Vaughn Tuckson
CIK 1511051 · EVP & Chief of Medical Affairs · last filed 2026-03-09
Reed Vaughn Tuckson is an EVP & Chief of Medical Affairs who has filed 54 SEC Form 4 insider transactions across 5 companies since 2011. The most recent filing, for HSIC, was dated Mar 9, 2026. Across all open-market trades the lifetime net is −$22.5M, making them a net seller over the disclosed history. Current disclosed insider exposure totals $1.0M across reported positions.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$1.02M
5
54
-$22.45M
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| HSIC | Director | 12,520 | $81.25 | $1.02M | $0 | 8 | 2026-03-09 |
| Adverum Biotechnologies, Inc. (ADVM) Delisted | Director | — | $4.36 | — | $0 | 6 | 2025-12-10 |
| CTI BIOPHARMA CORP (CTIC) Delisted | Director | 0 | $9.09 | $0 | $0 | 13 | 2023-06-26 |
| CTI BIOPHARMA CORP (TRGT) Delisted | Director | 536,662 | — | — | $0 | 10 | 2014-01-31 |
| UNITEDHEALTH GROUP INC (UNHw) Delisted | EVP & Chief of Medical Affairs | 116,943 | — | — | -$22.45M | 12 | 2012-06-07 |
Recent Filings
54 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2026-03-09 | HSIC | Grant (A) | +2,577 | $0 | EDGAR |
| 2025-12-10 | Adverum Biotechnologies, Inc. (ADVM) Delisted | Disp (D) | — | $0 | EDGAR |
| 2025-06-20 | Adverum Biotechnologies, Inc. (ADVM) Delisted | Grant (A) | — | $0 | EDGAR |
| 2025-06-12 | HSIC | Tax (F) | −487 | -$34.6K | EDGAR |
| 2025-03-06 | HSIC | Mixed | +2,272 | -$40.2K | EDGAR |
| 2024-06-20 | Adverum Biotechnologies, Inc. (ADVM) Delisted | Grant (A) | — | $0 | EDGAR |
| 2024-03-05 | HSIC | Mixed | +2,109 | -$38.1K | EDGAR |
| 2023-06-26 | CTI BIOPHARMA CORP (CTIC) Delisted | Mixed | −48,639 | -$442.6K | EDGAR |
| 2023-06-13 | Adverum Biotechnologies, Inc. (ADVM) Delisted | Grant (A) | — | $0 | EDGAR |
| 2023-04-07 | CTI BIOPHARMA CORP (CTIC) Delisted | Grant (A) | — | $0 | EDGAR |